In vivo ubiquitination and proteasome-mediated degradation of p53

Cancer Research

Volumn 56, Issue 11, 1996, Pages 2649-2654

  Maki, Carl G ^a   Huibregtse, Jon M ^a,b   Howley, Peter M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEASOME; PROTEIN P21; PROTEIN P53; PROTEINASE INHIBITOR; UBIQUITIN;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; GAMMA IRRADIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN STABILITY; WART VIRUS;

ACETYLCYSTEINE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; GENE EXPRESSION; HUMANS; LEUPEPTINS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINS;

EID: 0029952441     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Hollstein, M., Sidransky, B , Vogelstein, B., and Harris, C C p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991
2. Levine, A J., Momand, J , and Finlay, C. A. The p53 tumor suppressor gene. Nature (Lond ), 351: 453-455, 1991
3. Kastan, M B , Onyekwere, O., Sidransky, D , Vogelstein, B , and Craig, R W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51. 6304-6311, 1991.
4. Kuerbitz, S J , Flunkert, B S., Walsh, W. V., and Kastan, M. B Wild-type p53 is a cell cycle checkpoint determinant following irradiation Proc. Natl. Acad Sci USA, 89: 7491-7495, 1992
5. Maltzman, W., and Czyzyk, L. UV irradiation stimulates levels of p53 cellular tumor antigen in non transformed mouse cells Mol Cell Biol., 4: 1689-1694, 1984
6. Hubbert, N. L , Sedman, S. A , and Schiller, J. T Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J Virol , 66: 6237-6241, 1992
7. Scheffner, M., Munger, K., Byrne, J. C., and Howley, P. M. The state of p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl Acad. Sci. USA, 88: 5523-5527, 1991.
8. Huibregtse, J M., Scheffner, M , and Howley, P M A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J , 10: 4129-4135, 1991.
9. Wemess, B. A., Levine, A J., and Howley, P M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (Washington DC), 248: 76-79, 1990
10. Scheffner, M. Werness, B A., Huibregtse, J. M , Levine A. J., and Howley P M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
11. Scheffner, M . Huibregtse, J. M., Vierstra, R , and Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75 495-505, 1993
12. Scheffner, M., Nuber, U , and Huibregtse, J. M. Protein ubiquitination involving an E1-E2-E3 ubiquitin thioester cascade. Nature (Lond.), 373: 81-83, 1995
13. Chowdary, D R , Bermody, J. J., Jha, K K., and Ozer, H. L Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol , 14 1997-2003, 1994.
14. Ciechanover, A., DiGiuseppe, J. A., Bercovich, B , Orian, A., Richter, J. D., Schwartz, A. L , and Brodeur, G M. Degradation of nuclear oncoproteins by the ubiquitin system in vitro Proc Natl Acad. Sci USA, 88: 139-143, 1991
15. Chen, P., Johnson, P , Sommer, T., Jentsch, S , and Hochstrasser, M. Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MAT-2 repressor Cell. 74: 357-369, 1993.
16. Ciechanover, A The ubiquitin-proteasome proteolytic pathway. Cell, 79: 13-22, 1994.
17. Gallant, P., and Nigg, E. A. Cyclin B2 undergoes cell cycle-dependent nuclear translocation and, when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells. J Cell Biol., 117: 213-224, 1992
18. Glotzer, M., Murray, A. W., and Kirschner, M. W. Cyclin is degraded by the ubiquitin pathway Nature (Lond ), 349: 132-138, 1991.
19. Goldberg, A. L. The mechanism and functions of ATP-dependent proteases in bacterial and animal cells. Eur. J. Biochem., 203. 9-23, 1992.
20. Henkel, T., Machleidt, T. Alkalay, I , Kronke, M., and Baeuerle, P. A. Rapid proteolysis of I kappa B-α is necessary for activation of transcription factor NF-κ B. Nature (Lond ), 365. 182-185, 1993.
21. Hershko, A., and Ciechanover, A The ubiquitin system for protein degradation Annu Rev. Biochem , 61: 761-807, 1992
22. Minshull, J , Pines, R., Golsteyn, R., Standart, N , Mackie, S., Colman, A., Blow, J., Ruderman, J. V , Wu, M., and Hunt, T. The role of cyclin synthesis, modification and destruction in the control of cell division J. Cell Sci , 12: 77-97, 1989.
23. Murray, A , and Kirschner, M Dominoes and clocks the union of two views of the cell cycle Science (Washington DC), 246. 614-621, 1989.
24. Rechsteiner, M , Hoffman, L., and Dubiel, W. The multicatalytic and 26S proteases J. Biol Chem , 268, 6065-6068, 1993
25. 1 to S transition in S. cerevisiae Cell, 79: 233-244, 1994.
26. Trier, M., Staszewski, L. M., and Bohmann, D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the d domain. Cell, 78. 787-798, 1994
27. Rock, K L., Goldberg, A. L., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell, 78: 761-772, 1994
28. Palombella, V. J , Rando, O. J , Goldberg, A L., and Maniatis, T The ubiquitin-proteasome pathway is required for processing the NF-kB1 precursor protein and the activation of NF-kB. Cell, 78: 773-786, 1994.
29. Tsang, N-M., Nagasawa, H , Li, C., and Little, J. B Abrogation of p53 function by transfection of HPV16E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene, 10. 2403-2408, 1995.
30. Munger, K., Phelps, W C., Bubb, V., Howley, P. M , and Schlegel, R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63: 4417-4421, 1989
31. Fenteany, G , Standaert, R. F., Lane, W. S , Choi, S , Corey, E. J., and Schreiber, S. L Inhibition of proteasome activities and subunit-specific amino terminal threonine modification by lactacystin. Science (Washington DC), 268: 726-731, 1995
32. Guarino, L. A., Smith, G , and Dong, W. Ubiquitin is attached to membranes of baculovirus particles by a novel type of phospholipid anchor. Cell, 80. 301-309, 1995.
33. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
34. Florenes, V. A., Maelandsmo, G M , Andreassen, A , Myklebost, O., and Fodstad, O MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. J. Natl. Cancer Inst , 86: 1297-1302, 1994
35. Kastan, M. B., Zhan, Q , El-Deiry, W. S., Carrier, F , Jacks, T , Walsh, W V , Plunkett, B S , Vogelstein, B , and Fornace, A. J , Jr A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia Cell , 71. 587-597, 1992.
36. El-Deiry, W. S , Tokino, T , Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J M., Lin, D , Mercer, W E, Kinzler, K. W., and Vogelstein, B WAF1, a potential mediator of p53 tumor suppression Cell, 75. 817-825, 1993
37. Noda, A., Ning, S F., Venable, S. F., Pereira-Smith, O M , and Smith, J R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen Exp. Cell Res., 211: 90-98, 1994.
38. Xiong, Y , Hannon, G J , Zhang, H , Casco, D , Kobayashi, R., and Beach, D p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366. 701-704, 1993
39. Halvey, O , Novitch, B. G , Spicer, D. B., Skapek, S. X., Rhee, J , Hannon, G J., Beach, D., and Lassar, A. B Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD Science (Washington DC), 267. 1018-1021, 1995
40. Michieli, P., Chedid, M . Lin D., Pierce, J. H., Mercer, E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway Cancer Res , 54: 3391-3395, 1994
41. Parker, S. B , Eichele, G , Zhang, P., Rawls, A., Sands, A. T , Bradley, A., Olson, E. N , Harper, J W , and Elledge, S J. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
42. Skapek, S. X., Rhee, J., Spicer, D B , and Lassar, A. B Inhibition of myogenic differentiation in proliferating myoblasts by cyclin DI-dependent kinase. Science (Washington DC), 267 1022-1024, 1995.
43. Pagano, M., Tam, S W , Theodoras, A M., Beer-Romano, P , Del Sal, G., Chau, V , Yew, P R., Draetta, G F , and Rolfe, M Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science (Washington DC), 269 682-585, 1995
44. Tsurumi, C., Ishida, N , Tamura, T , Kakizuka, A., Nishida, E , Okumura, E Kishimoto, T , Inagaki, M , Okazaki, K., Sagata, N . Ichihara, A , and Tanaka, K Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases Mol Cell. Biol., 15: 5682-5687, 1995